AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS)

Issue No. 39 | September 12, 2007
View HTML version


AIDSinfo.nih.gov is pleased to provide you with a weekly update of highlights about what has happened in the world of HIV/AIDS treatment, prevention, and research. We hope you find this encapsulated view of HIV/AIDS news useful.



DHHS Pediatric Panel Notice on Nelfinavir FDA-Pfizer Letter The Department of Health and Human Services' (DHHS) Panel on Pediatric Antiretroviral Therapy & Management has issued a notice with updated recommendations on the use of nelfinavir in pediatric HIV patients. Full text of the notice is available from AIDSinfo: Pediatric Panel Notice on Nelfinavir DHHS Perinatal Panel Notice on Nelfinavir FDA-Pfizer Letter The Department of Health and Human Services' (DHHS) Panel on Treatment of HIV-Infected Pregnant Women & Prevention of Perinatal Transmission has issued a notice with updated recommendations on the use of nelfinavir in pregnant HIV patients. Full text of the notice is available from AIDSinfo: Perinatal Panel Notice on Nelfinavir

New HIV/AIDS trials have been added to ClinicalTrials.gov in the last 30 days. For a list of trials click here.

Please send comments or suggestions to
ContactUs@aidsinfo.nih.gov

You are currently subscribed to %%list.name%% as: %%emailaddr%%

To unsubscribe send a blank email to: leave-aidsinfo_e_news-1394849V@listmanager.aspensys.com

Subscribe to AIDSinfo list serv here

Click on the Live Help button on the AIDSinfo home page and communicate with the staff in "real time." -or-
Telephone: 800-448-0440
International Telephone:
301-519-0459
TTY/TDD: 888-480-3739
Fax: 301-519-6616
E-mail:
ContactUs@aidsinfo.nih.gov

DHHS Pediatric Panel Notice on Nelfinavir FDA-Pfizer Letter

DHHS Perinatal Panel Notice on Nelfinavir FDA-Pfizer Letter